CYTEK BIOSCIENCES INC's ticker is and the CUSIP is 23285D109. A total of 105 filers reported holding CYTEK BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $12,998,004 | -26.2% | 2,354,452 | +14.2% | 0.00% | 0.0% |
Q2 2023 | $17,612,064 | +2.5% | 2,062,302 | +10.3% | 0.00% | 0.0% |
Q1 2023 | $17,180,435 | +94111.6% | 1,869,470 | +4.7% | 0.00% | -33.3% |
Q4 2022 | $18,236 | -99.9% | 1,786,135 | +3.2% | 0.00% | -25.0% |
Q3 2022 | $25,475,000 | +107.3% | 1,730,668 | +51.1% | 0.00% | +100.0% |
Q2 2022 | $12,290,000 | +23.8% | 1,145,470 | +24.4% | 0.00% | +100.0% |
Q1 2022 | $9,929,000 | +71.3% | 921,140 | +159.4% | 0.00% | 0.0% |
Q4 2021 | $5,795,000 | -15.7% | 355,140 | +10.6% | 0.00% | 0.0% |
Q3 2021 | $6,874,000 | – | 321,108 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 1,300,000 | $13,273,000 | 8.92% |
Miura Global Management | 780,000 | $7,963,800 | 4.01% |
RA Capital Management | 13,381,054 | $136,620,561 | 2.77% |
HHLR ADVISORS, LTD. | 8,684,530 | $88,669,051 | 1.87% |
Brown Capital Management | 5,107,878 | $52,151,434 | 0.86% |
Perceptive Advisors | 1,289,534 | $13,166,142 | 0.37% |
Hillsdale Investment Management Inc. | 344,529 | $3,517,641 | 0.30% |
PURA VIDA INVESTMENTS, LLC | 420,749 | $4,295,847 | 0.22% |
FOX RUN MANAGEMENT, L.L.C. | 19,881 | $202,985 | 0.08% |
INNOVIS ASSET MANAGEMENT LLC | 14,565 | $148,709 | 0.07% |